VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 8 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2012. The put-call ratio across all filers is 1.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,795,000 | +121.7% | 163,444 | +52.0% | 0.01% | +100.0% |
Q1 2018 | $1,712,000 | -85.3% | 107,543 | -80.8% | 0.00% | -82.4% |
Q4 2017 | $11,623,000 | +41.6% | 559,173 | -2.4% | 0.02% | +30.8% |
Q3 2017 | $8,209,000 | -64.6% | 572,926 | -57.3% | 0.01% | -69.0% |
Q2 2017 | $23,208,000 | +263.5% | 1,341,377 | +131.7% | 0.04% | +223.1% |
Q1 2017 | $6,384,000 | +9.1% | 578,818 | +43.4% | 0.01% | -7.1% |
Q4 2016 | $5,854,000 | -27.6% | 403,667 | +23.5% | 0.01% | -30.0% |
Q3 2016 | $8,081,000 | +21.4% | 326,736 | -1.2% | 0.02% | +11.1% |
Q2 2016 | $6,658,000 | +45.2% | 330,565 | +90.4% | 0.02% | +38.5% |
Q1 2016 | $4,584,000 | -81.5% | 173,584 | -28.6% | 0.01% | -78.0% |
Q4 2015 | $24,720,000 | -47.2% | 243,222 | -7.3% | 0.06% | -50.0% |
Q3 2015 | $46,797,000 | +44.7% | 262,348 | +80.3% | 0.12% | +78.8% |
Q2 2015 | $32,347,000 | +20.7% | 145,504 | +7.7% | 0.07% | +26.9% |
Q1 2015 | $26,793,000 | +27.3% | 135,051 | -8.2% | 0.05% | +18.2% |
Q4 2014 | $21,054,000 | +10.9% | 147,054 | +1.5% | 0.04% | +12.8% |
Q3 2014 | $18,988,000 | +73.2% | 144,895 | +68.4% | 0.04% | +62.5% |
Q2 2014 | $10,960,000 | +4.2% | 86,018 | +6.3% | 0.02% | -4.0% |
Q1 2014 | $10,514,000 | +23.2% | 80,944 | +11.2% | 0.02% | +13.6% |
Q4 2013 | $8,536,000 | +1.9% | 72,793 | -9.2% | 0.02% | -4.3% |
Q3 2013 | $8,374,000 | +46.1% | 80,210 | +20.8% | 0.02% | +35.3% |
Q2 2013 | $5,732,000 | +120.8% | 66,372 | +92.0% | 0.02% | +88.9% |
Q1 2013 | $2,596,000 | +29.2% | 34,574 | +2.7% | 0.01% | +12.5% |
Q4 2012 | $2,009,000 | -27.9% | 33,669 | -33.1% | 0.01% | -27.3% |
Q3 2012 | $2,786,000 | +24.5% | 50,311 | +0.3% | 0.01% | +10.0% |
Q2 2012 | $2,238,000 | -59.1% | 50,155 | -50.7% | 0.01% | -58.3% |
Q1 2012 | $5,471,000 | – | 101,831 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |